These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24155810)

  • 21. Comparison of prescription reimbursement methodologies in Japan and the United States.
    Akaho E; MacLaughlin EJ; Takeuchi Y
    J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge, attitude, and practice of pharmacy professionals on generic medicines in Eastern Ethiopia: A cross-sectional study.
    Mohammed AS; Woldekidan NA; Mohammed FA
    PLoS One; 2020; 15(7):e0235205. PubMed ID: 32658918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generic Medicine Pricing Policies in Europe: Current Status and Impact.
    Dylst P; Simoens S
    Pharmaceuticals (Basel); 2010 Mar; 3(3):471-481. PubMed ID: 27713264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International comparison of generic medicine prices.
    Simoens S
    Curr Med Res Opin; 2007 Nov; 23(11):2647-54. PubMed ID: 17877848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use.
    Hassali MA; Alrasheedy AA; McLachlan A; Nguyen TA; Al-Tamimi SK; Ibrahim MI; Aljadhey H
    Saudi Pharm J; 2014 Dec; 22(6):491-503. PubMed ID: 25561861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does increased use of generic medicines by elders in Belgium help to contain escalating health care budgets?
    Dylst P; Vulto A; Simoens S
    J Aging Soc Policy; 2014; 26(3):266-80. PubMed ID: 24716815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
    Wouters OJ; Kanavos PG; McKEE M
    Milbank Q; 2017 Sep; 95(3):554-601. PubMed ID: 28895227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States.
    Vogler S; Habl C; Bogut M; Voncina L
    Croat Med J; 2011 Apr; 52(2):183-97. PubMed ID: 21495202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability.
    Dylst P; Vulto AG; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):345-53. PubMed ID: 24758569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remunerated patient care services and injections by pharmacists: An international update.
    Houle SKD; Carter CA; Tsuyuki RT; Grindrod KA
    J Am Pharm Assoc (2003); 2019; 59(1):89-107. PubMed ID: 30195440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating community pharmacists' perspectives and practices concerning generic medicines substitution in Saudi Arabia: A cross-sectional study.
    Alkhuzaee FS; Almalki HM; Attar AY; Althubiani SI; Almuallim WA; Cheema E; Hadi MA
    Health Policy; 2016 Dec; 120(12):1412-1419. PubMed ID: 28228231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European healthcare policies for controlling drug expenditure.
    Ess SM; Schneeweiss S; Szucs TD
    Pharmacoeconomics; 2003; 21(2):89-103. PubMed ID: 12515571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.
    Flood D; Mathieu I; Chary A; García P; Rohloff P
    BMC Health Serv Res; 2017 Jan; 17(1):27. PubMed ID: 28086866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration.
    Imfeld-Isenegger TL; Soares IB; Makovec UN; Horvat N; Kos M; van Mil F; Costa FA; Hersberger KE
    Res Social Adm Pharm; 2020 Aug; 16(8):1057-1066. PubMed ID: 31734100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The content of patient counseling about interchangeable medicines and generic substitution in Finnish community pharmacies - a survey of dispensers.
    Rainio R; Ahonen R; Timonen J
    BMC Health Serv Res; 2019 Dec; 19(1):956. PubMed ID: 31829174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capitation payment for pharmacy services: impact on generic substitution.
    Yesalis CE; Norwood GJ; Lipson DP; Helling DK; Fisher WP; Burmeister LF
    Med Care; 1980 Aug; 18(8):816-28. PubMed ID: 6997648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remuneration of medical specialists. Drivers of the differences between six European countries.
    Kok L; Boyle S; Lammers M; Tempelman C
    Health Policy; 2015 Sep; 119(9):1188-96. PubMed ID: 25960138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring community pharmacists' views on generic medicines: a nationwide study from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Int J Clin Pharm; 2011 Feb; 33(1):124-31. PubMed ID: 21365404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of French generic medicines retail market: why the use of generic medicines is limited.
    Dylst P; Vulto A; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):795-803. PubMed ID: 25095903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.